Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

FDA approves BioCryst’s Orladeyo for reducing hereditary angioedema attacks

December 4, 2020 Medical Communications, Sales and Marketing BioCryst, FDA, Orladeyo

BioCryst has scored FDA for its therapy Orladeyo (berotralstat) for reducing or preventing hereditary angioedema (HAE) attacks in patients over …
News
moderna

MSD cashes in on Moderna investment as FDA mulls COVID-19 vaccine approval

December 4, 2020 Medical Communications, Sales and Marketing MSD, Moderna

Moderna has wrestled its way to the forefront of the industry amidst the COVID-19 pandemic, becoming one of its most …
News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

December 2, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Image credit: CDC, Top 5, Vaccine

EMA receives Pfizer and BioNTech’s filing for conditional approval of COVID-19 vaccine in Europe – Published on 01/12/20
News
pharmafile_autumn_2020_front_cover

The Autumn 2020 edition of Pharmafile is available to read for free online now!

December 1, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing infectious diseases, pharmafile, rare disease, respiratory

The Autumn 2020 edition of Pharmafile is available to read for free online now! 2020 has seen almost unprecedented disruption …
News
avantor

Optimise your clinical trials with Avantor Clinical Services

December 1, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020 Campaign, Avantor, clinical trials, expertise

Serious diseases like COVID-19 put increasing pressure on researchers to find breakthrough treatments faster. Along with accelerated timelines, biopharma and …
News
cliche_hacker_and_binary_code_26614834084

AstraZeneca targeted by suspected North Korean hackers

November 27, 2020 Medical Communications

Hackers suspected to be operating from North Korea have tried to break into the systems of AstraZeneca, two people with …
News

Japan approves Astellas and FibroGen’s Evrenzo for chronic kidney disease patients currently not receiving dialysis

November 27, 2020 Medical Communications, Sales and Marketing Astellas, Japan, fibrogen

Japan’s Ministry of Health, Labour and Welfare (MHLW) has passed approval for Astellas and FibroGen’s Evrenzo (roxadustat) in the treatment …
News
1200px-razrabotka_vakciny

New trial expected for AstraZeneca’s COVID-19 vaccine

November 27, 2020 Medical Communications

AstraZeneca is expected to launch new global trials to assess the efficacy of its COVID-19 vaccine using a lower dosage.  …
News
1200px-european_flag_in_karlskrona_2011

EU fines Teva and Cephalon for keeping cheap sleep disorder medicine off the market

November 27, 2020 Medical Communications

The European Union has fined Teva and Cephalon for colluding to keep a cheap alternative sleep disorder medicine off the …
News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

November 27, 2020 Medical Communications

The top ten news stories this week once again focus on COVID-19 treatments, with the Canadian Government securing 26,000 doses …
News
pharmafocus_december_2020_cover

The December 2020 issue of Pharmafocus is available to read free online now!

November 24, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, clinical trials, diabetes, outsourcing

The final 2020 monthly edition of Pharmafocus is available to read for free online now! After a long and theatrical …
News
1200px-logo_of_the_world_health_organization

World Health Organization does not recommend using remdesivir to treat COVID-19

November 20, 2020 Medical Communications

The World Health Organization does not recommend using Gilead’s antiviral drug remdesivir to treat hospitalised COVID-19 patients, no matter how …
News

Eli Lilly and Ypsome partner to advance automated insulin delivery system

November 20, 2020 Medical Communications

Eli Lilly has entered into a global non-exclusive agreement with Ypsomed for the advancement of an automated insulin delivery system …
News
fdaoutsideweb

Pfizer and BioNTech to request FDA Emergency Use Authorisation for their COVID-19 vaccine today

November 20, 2020 Medical Communications, Sales and Marketing BioNTech, COVID-19, Pfizer, Vaccine

Pfizer and BioNTech are reportedly gearing up to submit a formal application for Emergency Use Authorisation to the FDA later …
News
influenza

First recombinant influenza vaccine approved in the European Union

November 20, 2020 Medical Communications, Sales and Marketing Europe, influenza, pharma

The European Commission (EC) has just approved its first recombinant influenza vaccine for the European Union, awarding marketing authorisation to …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025